Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma.
Arndt A, Neumann C, Riecke A, Bauer A, Müller M, Wölfle-Guter M, Grunert M, Busch H, Künstner A, von Bubnoff N, Fliedner S, Greinert D, Osius J, Nagarathinam K, Steinestel K, Gorantla SP, Gebauer N, Witte HM. Arndt A, et al. Among authors: von bubnoff n. Oncologist. 2024 Jul 3:oyae143. doi: 10.1093/oncolo/oyae143. Online ahead of print. Oncologist. 2024. PMID: 38960389 Free article.
Primary refractory plasmablastic lymphoma: A precision oncology approach.
Witte HM, Fähnrich A, Künstner A, Riedl J, Fliedner SMJ, Reimer N, Hertel N, von Bubnoff N, Bernard V, Merz H, Busch H, Feller A, Gebauer N. Witte HM, et al. Among authors: von bubnoff n. Front Oncol. 2023 Feb 27;13:1129405. doi: 10.3389/fonc.2023.1129405. eCollection 2023. Front Oncol. 2023. PMID: 36923431 Free PMC article.
Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCs.
Xie X, Patnana PK, Frank D, Schütte J, Al-Matary Y, Künstner A, Busch H, Ahmed H, Liu L, Engel DR, Dührsen U, Rosenbauer F, Von Bubnoff N, Lenz G, Khandanpour C. Xie X, et al. Among authors: von bubnoff n. Front Cell Dev Biol. 2023 Apr 5;11:866847. doi: 10.3389/fcell.2023.866847. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37091981 Free PMC article.
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6).
Witte HM, Riedl J, Künstner A, Fähnrich A, Ketzer J, Fliedner SMJ, Reimer N, Bernard V, von Bubnoff N, Merz H, Busch H, Feller A, Gebauer N. Witte HM, et al. Among authors: von bubnoff n. Target Oncol. 2023 Sep;18(5):749-765. doi: 10.1007/s11523-023-00983-5. Epub 2023 Jul 24. Target Oncol. 2023. PMID: 37488307 Free PMC article.
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Boddu VK, Zamzow P, Kramer MW, Merseburger AS, Gorantla SP, Klinger M, Cramer L, Sauer T, Gemoll T, von Bubnoff N, Gieseler F, Darabi M. Boddu VK, et al. Among authors: von bubnoff n. Cell Commun Signal. 2024 Feb 15;22(1):129. doi: 10.1186/s12964-024-01508-x. Cell Commun Signal. 2024. PMID: 38360687 Free PMC article.
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
Künstner A, Schwarting J, Witte HM, Xing P, Bernard V, Stölting S, Lohneis P, Janke F, Salehi M, Chen X, Kusch K, Sültmann H, Chteinberg E, Fischer A, Siebert R, von Bubnoff N, Merz H, Busch H, Feller AC, Gebauer N. Künstner A, et al. Among authors: von bubnoff n. Leukemia. 2024 May;38(5):1086-1098. doi: 10.1038/s41375-024-02240-8. Epub 2024 Apr 10. Leukemia. 2024. PMID: 38600314 Free PMC article.
Case report: Tenosynovial giant cell tumor.
Fähnrich A, Gasimova Z, Maluje Y, Ott F, Sievert H, Fliedner S, Reimer N, Künstner A, Gebauer N, Kebenko M, von Bubnoff N, Kirfel J, Sailer VW, Röcken C, Konukiewitz B, Klapper W, Frydrychowicz A, Mogadas S, Huebner G, Busch H, Khandanpour C. Fähnrich A, et al. Among authors: von bubnoff n. Front Oncol. 2024 Sep 26;14:1445427. doi: 10.3389/fonc.2024.1445427. eCollection 2024. Front Oncol. 2024. PMID: 39391235 Free PMC article.
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C, de Andrade Krätzig N, Pecoraro M, Lange S, Seifert P, von Frankenberg C, Untch J, Zuleger G, Wilhelm M, Zolg DP, Dreyer FS, Bräunlein E, Engleitner T, Uhrig S, Boxberg M, Steiger K, Slotta-Huspenina J, Ochsenreither S, von Bubnoff N, Bauer S, Boerries M, Jost PJ, Schenck K, Dresing I, Bassermann F, Friess H, Reim D, Grützmann K, Pfütze K, Klink B, Schröck E, Haller B, Kuster B, Mann M, Weichert W, Fröhling S, Rad R, Hiltensperger M, Krackhardt AM. Tretter C, et al. Among authors: von frankenberg c, von bubnoff n. Nat Commun. 2023 Aug 2;14(1):4632. doi: 10.1038/s41467-023-39570-7. Nat Commun. 2023. PMID: 37532709 Free PMC article.
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C, de Andrade Krätzig N, Pecoraro M, Lange S, Seifert P, von Frankenberg C, Untch J, Zuleger G, Wilhelm M, Zolg DP, Dreyer FS, Bräunlein E, Engleitner T, Uhrig S, Boxberg M, Steiger K, Slotta-Huspenina J, Ochsenreither S, von Bubnoff N, Bauer S, Boerries M, Jost PJ, Schenck K, Dresing I, Bassermann F, Friess H, Reim D, Grützmann K, Pfütze K, Klink B, Schröck E, Haller B, Kuster B, Mann M, Weichert W, Fröhling S, Rad R, Hiltensperger M, Krackhardt AM. Tretter C, et al. Among authors: von frankenberg c, von bubnoff n. Nat Commun. 2024 Mar 15;15(1):2364. doi: 10.1038/s41467-024-46724-8. Nat Commun. 2024. PMID: 38491045 Free PMC article. No abstract available.
158 results